About GLN-APREMILAST

GLN-APREMILAST is a prescription medication containing the active ingredient Apremilast, a phosphodiesterase 4 (PDE4) inhibitor. It is used to treat moderate to severe plaque psoriasis in adults who have tried other treatments without success.

Key Benefits & Uses

Treatment of moderate to severe plaque psoriasis in adults.
Reduction of symptoms associated with psoriatic arthritis.
Improvement in skin symptoms and quality of life for patients with psoriasis.

Active Ingredient & Action

APREMILAST works by inhibiting the activity of phosphodiesterase 4 (PDE4), an enzyme involved in the production of pro-inflammatory mediators. By blocking PDE4, Apremilast reduces inflammation and slows down the growth of skin cells, leading to improved symptoms and quality of life for patients with psoriasis.

Important Notes

GLN-APREMILAST is available by prescription only and should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and treatment schedule to minimize the risk of side effects. Patients with a history of depression, anxiety, or other mental health conditions should be closely monitored while taking GLN-APREMILAST.